000309604 001__ 309604
000309604 005__ 20260202155628.0
000309604 0247_ $$2doi$$a10.1038/s41598-026-37118-5
000309604 0247_ $$2pmid$$apmid:41617901
000309604 037__ $$aDKFZ-2026-00254
000309604 041__ $$aEnglish
000309604 082__ $$a600
000309604 1001_ $$00000-0002-2164-4644$$aGellrich, Frank Friedrich$$b0
000309604 245__ $$a¹H-NMR serum metabolomic profiling from clinical routine identifies signatures of progressive melanoma metastasis.
000309604 260__ $$a[London]$$bSpringer Nature$$c2026
000309604 3367_ $$2DRIVER$$aarticle
000309604 3367_ $$2DataCite$$aOutput Types/Journal article
000309604 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1770044009_1634685
000309604 3367_ $$2BibTeX$$aARTICLE
000309604 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000309604 3367_ $$00$$2EndNote$$aJournal Article
000309604 500__ $$a#DKTKZFB9# / #NCTZFB9# / epub
000309604 520__ $$aEarly detection of active melanoma metastasis is crucial. Serum metabolomics may offer non-invasive biomarkers, but real-world applicability needs validation. This study aimed to identify ¹H-NMR-based serum metabolic signatures for active metastasis in a large clinical cohort. Serum from 963 melanoma patients (1698 samples) underwent ¹H-NMR spectroscopy. Patients were classified by active metastasis status. OPLS-DA and RFE followed by logistic regression models were developed on a patient-level training/test split. Subgroup analyses assessed signatures related to Immune Checkpoint Inhibitor (ICI) therapy, brain metastases, and BRAF status. Models for active metastasis showed moderate test set discrimination (Area Under the Curve [AUCs]: OPLS-DA 0.609, RFE 0.630). The RFE-model highlighted seven significant metabolites: increased pyruvate, phenylalanine, acetoacetate, glutamate, glucose, and decreased histidine and citrate were associated with active metastasis. OPLS-DA yielded concordant metabolites. Subgroup analyses revealed distinct metabolic associations, e.g., for ICI therapy (citrate, RFE AUC 0.721) and BRAF status (acetate, RFE AUC 0.655), but limited performance for brain metastases (RFE AUC 0.553). ¹H-NMR serum metabolomics detects systemic metabolic alterations of active melanoma metastasis with moderate accuracy in a real-world setting. Identified disruptions in energy and amino acid metabolism offer pathobiological insights and warrant investigation for multimodal biomarker panels.
000309604 536__ $$0G:(DE-HGF)POF4-899$$a899 - ohne Topic (POF4-899)$$cPOF4-899$$fPOF IV$$x0
000309604 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000309604 650_7 $$2Other$$aBiomarkers
000309604 650_7 $$2Other$$aMelanoma
000309604 650_7 $$2Other$$aMetabolic profiling
000309604 650_7 $$2Other$$aPredictive model
000309604 650_7 $$2Other$$aTumor metabolism
000309604 7001_ $$00009-0001-0859-2915$$aHufnagel, Cosima$$b1
000309604 7001_ $$00000-0002-7248-4599$$aFunk, Alexander M$$b2
000309604 7001_ $$aJonas, Sophie$$b3
000309604 7001_ $$0P:(DE-He78)ad602776b59c10ecdda49cbb2d533cd4$$aAltmann, Heidi$$b4
000309604 7001_ $$00000-0001-5703-324X$$aHobelsberger, Sarah$$b5
000309604 7001_ $$00000-0001-9094-4512$$aSteininger, Julian$$b6
000309604 7001_ $$aFeige, Christina$$b7
000309604 7001_ $$00000-0003-2543-852X$$aTasdogan, Alpaslan$$b8
000309604 7001_ $$00000-0002-1869-5141$$aChavakis, Triantafyllos$$b9
000309604 7001_ $$00000-0002-8327-8475$$aBeissert, Stefan$$b10
000309604 7001_ $$00000-0003-4340-9706$$aMeier, Friedegund$$b11
000309604 7001_ $$00000-0001-5832-1673$$aMirtschink, Peter$$b12
000309604 7001_ $$00000-0002-7625-343X$$aSteiner, Gerald$$b13
000309604 773__ $$0PERI:(DE-600)2615211-3$$a10.1038/s41598-026-37118-5$$pnn$$tScientific reports$$vnn$$x2045-2322$$y2026
000309604 909CO $$ooai:inrepo02.dkfz.de:309604$$pVDB
000309604 9101_ $$0I:(DE-588b)2036810-0$$60000-0002-2164-4644$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000309604 9101_ $$0I:(DE-588b)2036810-0$$60009-0001-0859-2915$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000309604 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)ad602776b59c10ecdda49cbb2d533cd4$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000309604 9101_ $$0I:(DE-588b)2036810-0$$60000-0001-5703-324X$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000309604 9101_ $$0I:(DE-588b)2036810-0$$60000-0001-9094-4512$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000309604 9101_ $$0I:(DE-588b)2036810-0$$60000-0003-2543-852X$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000309604 9101_ $$0I:(DE-588b)2036810-0$$60000-0003-4340-9706$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000309604 9131_ $$0G:(DE-HGF)POF4-899$$1G:(DE-HGF)POF4-890$$2G:(DE-HGF)POF4-800$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000309604 9141_ $$y2026
000309604 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bSCI REP-UK : 2022$$d2025-11-07
000309604 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-11-07
000309604 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-11-07
000309604 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2025-11-07
000309604 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2025-08-21T14:09:21Z
000309604 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2025-08-21T14:09:21Z
000309604 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2025-08-21T14:09:21Z
000309604 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2025-11-07
000309604 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2025-11-07
000309604 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-11-07
000309604 915__ $$0StatID:(DE-HGF)1150$$2StatID$$aDBCoverage$$bCurrent Contents - Physical, Chemical and Earth Sciences$$d2025-11-07
000309604 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2025-11-07
000309604 915__ $$0StatID:(DE-HGF)1040$$2StatID$$aDBCoverage$$bZoological Record$$d2025-11-07
000309604 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-11-07
000309604 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-11-07
000309604 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-11-07
000309604 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2025-11-07
000309604 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2025-11-07
000309604 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2025-11-07
000309604 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2025-11-07
000309604 9201_ $$0I:(DE-He78)ED01-20160331$$kED01$$lDKTK Koordinierungsstelle Essen/Düsseldorf$$x0
000309604 9201_ $$0I:(DE-He78)DD04-20160331$$kDD04$$lKoordinierungsstelle NCT Dresden$$x1
000309604 9201_ $$0I:(DE-He78)WT01-20160331$$kWT01$$lKoordinierungsstelle NCT West$$x2
000309604 980__ $$ajournal
000309604 980__ $$aVDB
000309604 980__ $$aI:(DE-He78)ED01-20160331
000309604 980__ $$aI:(DE-He78)DD04-20160331
000309604 980__ $$aI:(DE-He78)WT01-20160331
000309604 980__ $$aUNRESTRICTED